Open Congress : Major Bill Actions in Orphan drugs2007-10-19T00:00:00Zopencongress.orgtag:opencongress.org,2007:/issue_feed/7437Bill Introduced: S.2210 Medical Innovation Prize Act of 2007tag:opencongress.org,2007-10-19:/action/1335552007-10-19T00:00:00Z
A bill to provide incentives for investment in research and development for new medicines, to enhance access to new medicines, and for other purposes.<br /><br /> Bill Enacted: H.R.3580 Prescription Drug User Fee Amendments of 2007tag:opencongress.org,2007-09-27:/action/1307492007-09-27T00:00:00Z
To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and for medical devices, to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs, and for other purposes.<br /><br />September 27, 2007: Became Public Law No: 110-85. Bill Signed by President: H.R.3580 Prescription Drug User Fee Amendments of 2007tag:opencongress.org,2007-09-27:/action/1307482007-09-27T00:00:00Z
To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and for medical devices, to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs, and for other purposes.<br /><br />September 27, 2007: Signed by President. Bill Sent To President: H.R.3580 Prescription Drug User Fee Amendments of 2007tag:opencongress.org,2007-09-26:/action/1305242007-09-26T00:00:00Z
To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and for medical devices, to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs, and for other purposes.<br /><br />September 26, 2007: Presented to President. Bill Sent To President: H.R.3580 Prescription Drug User Fee Amendments of 2007tag:opencongress.org,2007-09-20:/action/1299392007-09-20T00:00:00Z
To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and for medical devices, to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs, and for other purposes.<br /><br />September 20, 2007: Cleared for White House. Bill Introduced: H.R.3580 Prescription Drug User Fee Amendments of 2007tag:opencongress.org,2007-09-19:/action/1295902007-09-19T00:00:00Z
To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and for medical devices, to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs, and for other purposes.<br /><br /> Bill Introduced: S.2042 SMA Treatment Acceleration Acttag:opencongress.org,2007-09-12:/action/1289462007-09-12T00:00:00Z
A bill to authorize the Secretary of Health and Human Services to conduct activities to rapidly advance treatments for spinal muscular atrophy, neuromuscular disease, and other pediatric diseases, and for other purposes.<br /><br /> Bill Introduced: H.R.3334 SMA Treatment Acceleration Acttag:opencongress.org,2007-08-02:/action/1269262007-08-02T00:00:00Z
To authorize the Secretary of Health and Human Services to conduct activities to rapidly advance treatments for spinal muscular atrophy, neuromuscular disease, and other pediatric diseases, and for other purposes.<br /><br /> Bill Introduced: H.R.3264 American Life Sciences Competitiveness Act of 2007tag:opencongress.org,2007-07-31:/action/1341362007-07-31T00:00:00Z
To amend the Internal Revenue Code of 1986 to modernize the tax treatment of biomedical research corporations.<br /><br /> Bill Introduced: H.R.2900 Food and Drug Administration Amendments Act of 2007tag:opencongress.org,2007-06-28:/action/1204122007-06-28T00:00:00Z
To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and for medical devices, to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs, and for other purposes.<br /><br /> Bill Introduced: S.1082 Pharmaceutical Market Access and Drug Safety Act of 2007tag:opencongress.org,2007-04-10:/action/1081992007-04-10T00:00:00Z
An act to amend the Federal Food, Drug, and cosmetic Act and the Public Health Service Act to reauthorize drug and device user fees and ensure the safety of medical products, and for other purposes.<br /><br /> Bill Introduced: H.R.1391 Vaccines for the Future Act of 2007tag:opencongress.org,2007-03-07:/action/955272007-03-07T00:00:00Z
To accelerate efforts to develop vaccines for diseases primarily affecting developing countries, and for other purposes.<br /><br /> Bill Introduced: S.569 Vaccines for the Future Act of 2007tag:opencongress.org,2007-02-13:/action/932892007-02-13T00:00:00Z
A bill to accelerate efforts to develop vaccines for diseases primarily affecting developing countries and for other purposes.<br /><br /> Bill Introduced: H.R.5115 U.S. Healthcare Technologies Competitiveness Act of 2006tag:opencongress.org,2006-04-06:/action/509992006-04-06T00:00:00Z
To amend the Internal Revenue Code of 1986 to modernize the tax treatment of biomedical research corporations.<br /><br /> Bill Introduced: S.2564 Biodefense and Pandemic Vaccine and Drug Development Act of 2006tag:opencongress.org,2006-04-06:/action/510492006-04-06T00:00:00Z
A bill to prepare and strengthen the biodefenses of the United States against deliberate, accidental, and natural outbreaks of illness, and for other purposes.<br /><br /> Bill Introduced: H.R.5080 Orphan Drug Tax Credit Act of 2006tag:opencongress.org,2006-04-04:/action/513782006-04-04T00:00:00Z
To provide for the expansion of human clinical trials qualifying for the orphan drug credit.<br /><br /> Bill Introduced: S.1873 Biodefense and Pandemic Vaccine and Drug Development Act of 2005tag:opencongress.org,2005-10-17:/action/605162005-10-17T00:00:00Z
A bill to prepare and strengthen the biodefenses of the United States against deliberate, accidental, and natural outbreaks of illness, and for other purposes.<br /><br /> Bill Introduced: S.975 Project BioShield II Act of 2005tag:opencongress.org,2005-04-28:/action/663132005-04-28T00:00:00Z
A bill to provide incentives to increase research by private sector entities to develop medical countermeasures to prevent, detect, identify, contain, and treat illnesses, including those associated with biological, chemical, nuclear, or radiological weapons attack or an infectious disease outbreak, and for other purposes.<br /><br /> Bill Introduced: H.R.417 Medical Innovation Prize Act of 2005tag:opencongress.org,2005-01-26:/action/786622005-01-26T00:00:00Z
To provide incentives for investment in research and development for new medicines, to enhance access to new medicines, and for other purposes.<br /><br />